Narrow Results Clear All
Search results for "Endocrinology"
- Organizational Policy/Guidelines
Journal Article > Commentary
American College of Endocrinology and American Association of Clinical Endocrinologists position statement on patient safety and medical system errors in diabetes and endocrinology.
Bates D, Clark NG, Cook RI, et al; Writing Committee on Patient Safety and Medical System Errors in Diabetes and Endocrinology. Endocr Pract. 2005;11:197-202.
The authors report on the results of a consensus conference that focused on safety for patients with diabetes and other endocrine diseases. They list the recommendations from the multidisciplinary expert panel convened for the conference.
Journal Article > Organizational Policy/Guidelines
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Diabetes Care. 2015;38:716-722.
Insulin is a high-alert medication that can lead to harm if incorrectly administered. Insulin pump problems can be caused by human, mechanical, or drug stability failures. This policy statement describes ways to use adverse event data, manufacturer information, and technical specifications to enhance the safety of insulin therapy.